Adherence enhancing interventions for oral anticancer agents: A systematic review

Cancer Treatment Reviews

Volumn 40, Issue 1, 2014, Pages 102-108

  Mathes, Tim ^a   Antoine, Sunya Lee ^a   Pieper, Dawid ^a   Eikermann, Michaela ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Medication adherence; Neoplasms; Oncology; Oral anticancer agents; Oral chemotherapy; Patient compliance

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; ERLOTINIB; IMATINIB; PREDNISOLONE; PREDNISONE; SORAFENIB; SUNITINIB;

ACUTE LEUKEMIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; COLORECTAL CANCER; DRUG BLOOD LEVEL; GASTROINTESTINAL STROMAL TUMOR; HODGKIN DISEASE; HUMAN; INTERVENTION STUDY; KIDNEY CANCER; LIVER CANCER; LYMPHOMA; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOLID TUMOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

MEDICATION ADHERENCE; NEOPLASMS; ONCOLOGY; ORAL ANTICANCER AGENTS; ORAL CHEMOTHERAPY; PATIENT COMPLIANCE;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; MEDICATION ADHERENCE; NEOPLASMS; TREATMENT OUTCOME;

EID: 84887065550     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2013.07.004     Document Type: Review

References (26)

1. Banna G.L., Collova E., Gebbia V., et al. Anticancer oral therapy: emerging related issues. Cancer Treat Rev 2010, 36(8):595-605. Epub 2010/06/24.
2. Cramer J.A., Roy A., Burrell A., et al. Medication compliance and persistence: terminology and definitions. Value Health 2008, 11(1):44-47. Epub 2008/02/02.
3. Wood L. A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs 2012, 16(4):432-438. Epub 2011/11/05.
4. Foulon V., Schoffski P., Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 2011, 66(2):85-96.
5. Partridge A.H., Avorn J., Wang P.S., Winer E.P. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002, 94(9):652-661. Epub 2002/05/02.
6. Fallowfield L., Atkins L., Catt S., et al. Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol 2006, 17(2):205-210. Epub 2005/10/22.
7. Noens L., van Lierde M.A., De Bock R., et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood 2009, 113(22):5401-5411. Epub 2009/04/08.
8. Xu S., Yang Y., Tao W., et al. Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer. Breast Cancer Res Treat 2012, 136(2):495-502. Epub 2012/10/16.
9. Verbrugghe M., Verhaeghe S., Lauwaert K., Beeckman D., Van Hecke A. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treatment Rev 2013, 39(6):610-621.
10. World Health Organization. Adherence to long-term therapies: evidence for action; 2003.
11. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, (2):CD0000111. Epub 2008/04/22.
12. Ruddy K., Mayer E., Partridge A. Patient adherence and persistence with oral anticancer treatment. Cancer J Clin 2009, 59(1):56-66.
13. Hartling L., Bond K., Harvey K., Santaguida P.L., Dryden D.M., Viswanathan M. Developing and testing a tool for the classification of study designs in systematic reviews of interventions and exposures. Rockville MD 2010.
14. Cochrane Effective Practice and Organization of Care Group. Suggested risk of bias criteria for EPOC reviews. [cited 2012 01.12.2012]; Available from: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf.
15. Levine A.M., Richardson J.L., Marks G., et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol 1987, 5(9):1469-1476.
16. Richardson J.L., Marks G., Johnson C.A., et al. Path model of multidimensional compliance with cancer therapy. Health psychol 1987, 6(3):183-207.
17. Moon J.H., Sohn S.K., Kim S.N., et al. Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients. Med Oncol 2012, 29(2):1179-1185.
18. Simons S., Ringsdorf S., Braun M., et al. Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 2011, 19(7):1009-1018.
19. Khandelwal N., Duncan I., Ahmed T., Rubinstein E., Pegus C. Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions. J Natl Compr Canc Netw 2012, 10(5):618-625.
20. MacIntosh P.W., Pond G.R., Pond B.J., Leung V., Siu L.L. A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes: Original article. Eur J Cancer Care 2007, 16(4):380-386.
21. Tschida S.J., Aslam S., Lal L.S., et al. Outcomes of a specialty pharmacy program for oral oncology medications. Am J Pharm Benefits 2012, 4(4):165-174.
22. Keogh-Brown M.R., Bachmann M.O., Shepstone L., et al. Contamination in trials of educational interventions. Health Technol Assess 2007, 11(43). iii,ix-107; Epub 2007/10/16.
23. Gorenoi V., Schoenermark M.P., Hagen A., Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes (Structured abstract). Cologne: German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Internet]. 2007. Available from: http://www.mrw.interscience.wiley.com/cochrane/clhta/articles/HTA-32008100213/frame.html.
24. Akerblad A.C., Bengtsson F., Holgersson M., von Knorring L., Ekselius L. Identification of primary care patients at risk of nonadherence to antidepressant treatment. Patient Prefer Adherence 2008, 2:379-386. Epub 2008/01/01.
25. Balfour L., Tasca G.A., Kowal J., et al. Development and validation of the HIV Medication Readiness Scale. Assessment 2007, 14(4):408-416. Epub 2007/11/08.
26. Egger M., Zellweger-Zahner T., Schneider M., Junker C., Lengeler C., Antes G. Language bias in randomized controlled trials published in English and German. Lancet 1997, 350(9074):326-329. Epub 1997/08/02.